These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 17590239)

  • 1. A Caenorhabditis elegans model of tau hyperphosphorylation: induction of developmental defects by transgenic overexpression of Alzheimer's disease-like modified tau.
    Brandt R; Gergou A; Wacker I; Fath T; Hutter H
    Neurobiol Aging; 2009 Jan; 30(1):22-33. PubMed ID: 17590239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human amyloid β peptide and tau co-expression impairs behavior and causes specific gene expression changes in Caenorhabditis elegans.
    Wang C; Saar V; Leung KL; Chen L; Wong G
    Neurobiol Dis; 2018 Jan; 109(Pt A):88-101. PubMed ID: 28982592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of tau aggregation in a novel Caenorhabditis elegans model of tauopathy mitigates proteotoxicity.
    Fatouros C; Pir GJ; Biernat J; Koushika SP; Mandelkow E; Mandelkow EM; Schmidt E; Baumeister R
    Hum Mol Genet; 2012 Aug; 21(16):3587-603. PubMed ID: 22611162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy.
    Kraemer BC; Zhang B; Leverenz JB; Thomas JH; Trojanowski JQ; Schellenberg GD
    Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9980-5. PubMed ID: 12872001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTL-1 regulates neuronal integrity and lifespan in C. elegans.
    Chew YL; Fan X; Götz J; Nicholas HR
    J Cell Sci; 2013 May; 126(Pt 9):2079-91. PubMed ID: 23525010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of human tau 3D structure, and interplay between O-β-GlcNAc and phosphorylation modifications in Alzheimer's disease: C. elegans as a suitable model to study these interactions in vivo.
    Ahmad W; Shabbiri K; Ahmad I
    Biochem Biophys Res Commun; 2020 Jul; 528(3):466-472. PubMed ID: 32499112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SUT-1 enables tau-induced neurotoxicity in C. elegans.
    Kraemer BC; Schellenberg GD
    Hum Mol Genet; 2007 Aug; 16(16):1959-71. PubMed ID: 17576746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SPOP loss of function protects against tauopathy.
    Eck RJ; Kow RL; Black AH; Liachko NF; Kraemer BC
    Proc Natl Acad Sci U S A; 2023 Jan; 120(1):e2207250120. PubMed ID: 36574656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic Dendra2::tau expression allows in vivo monitoring of tau proteostasis in Caenorhabditis elegans.
    Han M; Saxton A; Currey H; Waldherr SM; Liachko NF; Kraemer BC
    Dis Model Mech; 2024 Mar; 17(3):. PubMed ID: 38469687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tau-mediated cytotoxicity in a pseudohyperphosphorylation model of Alzheimer's disease.
    Fath T; Eidenmüller J; Brandt R
    J Neurosci; 2002 Nov; 22(22):9733-41. PubMed ID: 12427828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epibrassinolide prevents tau hyperphosphorylation via GSK3β inhibition in vitro and improves Caenorhabditis elegans lifespan and motor deficits in combination with roscovitine.
    Obakan Yerlikaya P; Arısan ED; Coker Gurkan A; Okumus OO; Yenigun T; Ozbey U; Kara M; Palavan Unsal N
    Amino Acids; 2021 Sep; 53(9):1373-1389. PubMed ID: 34386848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the molecular basis of Alzheimer's disease using a Caenorhabditis elegans model system.
    Ewald CY; Li C
    Brain Struct Funct; 2010 Mar; 214(2-3):263-83. PubMed ID: 20012092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axon Injury-Induced Autophagy Activation Is Impaired in a
    Ko SH; Gonzalez G; Liu Z; Chen L
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caenorhabditis elegans as an experimental tool for the study of complex neurological diseases: Parkinson's disease, Alzheimer's disease and autism spectrum disorder.
    Calahorro F; Ruiz-Rubio M
    Invert Neurosci; 2011 Dec; 11(2):73-83. PubMed ID: 22068627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of the ubiquitin ligase CHIP leads to the accumulation, but not the aggregation, of both endogenous phospho- and caspase-3-cleaved tau species.
    Dickey CA; Yue M; Lin WL; Dickson DW; Dunmore JH; Lee WC; Zehr C; West G; Cao S; Clark AM; Caldwell GA; Caldwell KA; Eckman C; Patterson C; Hutton M; Petrucelli L
    J Neurosci; 2006 Jun; 26(26):6985-96. PubMed ID: 16807328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sut-6/NIPP1 modulates tau toxicity.
    Kow RL; Black AH; Henderson BP; Kraemer BC
    Hum Mol Genet; 2023 Jul; 32(14):2292-2306. PubMed ID: 37000013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caenorhabditis elegans hub genes that respond to amyloid beta are homologs of genes involved in human Alzheimer's disease.
    Godini R; Pocock R; Fallahi H
    PLoS One; 2019; 14(7):e0219486. PubMed ID: 31291334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invertebrate models of Alzheimer's disease.
    Link CD
    Genes Brain Behav; 2005 Apr; 4(3):147-56. PubMed ID: 15810903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective disruption of Drp1-independent mitophagy and mitolysosome trafficking by an Alzheimer's disease relevant tau modification in a novel Caenorhabditis elegans model.
    Guha S; Cheng A; Carroll T; King D; Koren SA; Swords S; Nehrke K; Johnson GVW
    Genetics; 2022 Aug; 222(1):. PubMed ID: 35916724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DOPA Decarboxylase Modulates Tau Toxicity.
    Kow RL; Sikkema C; Wheeler JM; Wilkinson CW; Kraemer BC
    Biol Psychiatry; 2018 Mar; 83(5):438-446. PubMed ID: 28751068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.